Cerevel Therapeutics Holdings Inc (DELISTED) (CERE:DL)
44.96
0.00 (0.00%)
USD |
NASDAQ |
Aug 01, 16:00
Cerevel Therapeutics Holdings Price: 44.96 for Aug. 1, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 01, 2024 | 44.96 | 44.96 | 44.96 | 44.96 | 0.000 |
| Jul 31, 2024 | 44.99 | 44.99 | 44.96 | 44.96 | 15.10M |
| Jul 30, 2024 | 44.45 | 44.68 | 44.44 | 44.63 | 1.702M |
| Jul 29, 2024 | 44.61 | 44.63 | 44.36 | 44.41 | 3.789M |
| Jul 26, 2024 | 44.42 | 44.66 | 44.38 | 44.62 | 2.052M |
| Jul 25, 2024 | 43.78 | 44.54 | 43.75 | 44.40 | 7.071M |
| Jul 24, 2024 | 43.37 | 43.49 | 43.33 | 43.37 | 1.243M |
| Jul 23, 2024 | 43.50 | 43.53 | 43.32 | 43.40 | 1.345M |
| Jul 22, 2024 | 43.13 | 43.61 | 43.13 | 43.44 | 2.198M |
| Jul 19, 2024 | 42.74 | 42.91 | 42.53 | 42.90 | 2.242M |
| Jul 18, 2024 | 42.50 | 43.10 | 42.50 | 42.70 | 2.626M |
| Jul 17, 2024 | 42.40 | 42.74 | 42.23 | 42.72 | 1.483M |
| Jul 16, 2024 | 41.90 | 42.68 | 41.73 | 42.45 | 1.671M |
| Jul 15, 2024 | 40.27 | 41.92 | 40.19 | 41.90 | 2.020M |
| Jul 12, 2024 | 41.16 | 41.16 | 40.24 | 40.31 | 976172.0 |
| Jul 11, 2024 | 41.23 | 41.28 | 40.66 | 41.05 | 1.287M |
| Jul 10, 2024 | 40.68 | 40.97 | 40.30 | 40.93 | 951432.0 |
| Jul 09, 2024 | 40.46 | 40.56 | 40.04 | 40.53 | 1.221M |
| Jul 08, 2024 | 40.75 | 40.95 | 39.91 | 40.59 | 1.578M |
| Jul 05, 2024 | 40.22 | 41.02 | 40.05 | 40.96 | 1.553M |
| Jul 03, 2024 | 41.47 | 41.57 | 39.16 | 40.30 | 4.681M |
| Jul 02, 2024 | 41.15 | 41.29 | 40.95 | 41.23 | 2.445M |
| Jul 01, 2024 | 41.17 | 41.49 | 40.72 | 41.35 | 1.548M |
| Jun 28, 2024 | 40.60 | 41.54 | 40.52 | 40.89 | 12.16M |
| Jun 27, 2024 | 39.00 | 42.00 | 38.91 | 40.50 | 3.444M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
9.82
Minimum
Nov 05 2020
44.96
Maximum
Jul 31 2024
27.45
Average
27.98
Median
Price Benchmarks
| AbbVie Inc | 193.47 |
| Amgen Inc | 337.29 |
| Biogen Inc | 199.36 |
| Gilead Sciences Inc | 83.94 |
| Eli Lilly and Co | 921.49 |
Price Related Metrics
| Price to Book Value | 14.51 |
| Earnings Yield | -6.07% |
| Market Cap | 8.191B |